NSE › Healthcare

GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

NSE · Healthcare · Drug Manufacturers - General

₹2,662.30+0.26%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹995 cr
Revenue YoY
+4.6%
Net profit
₹278 cr
Profit YoY
+5.7%
EPS
₹9.89
EPS estimate
₹11.29
Net margin
27.9%

EPS came in at 9.89 against a street estimate of 11.29 — a miss of 12.4%.

Key statistics

Market cap
₹44,910 cr
P/E
43.4
Forward P/E
0.0
P/B
19.84
Book value
₹133.84
EPS (TTM)
₹61.07
Dividend yield
2.18%
52-week high
₹2,823.14
52-week low
₹2,088.10
50-day MA
₹2,363.26
200-day MA
₹2,441.17
Beta
0.04

Analyst view

with an average price target of ₹2,969.75.

Shareholding

Promoters
75.64%
Institutions
8.53%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for GlaxoSmithKline Pharmaceuticals Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.